ACADIAN ASSET MANAGEMENT LLC

Holdings History for Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH)

Symbol: TBPH on Nasdaq
Investment type: Equity / Ordinary Share $0.00001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.04%	+0%	$21,806,000	1,165,959	+76,578	+7%	$18.70	Q4 2025
30 Sep 2025	0.03%	+0.02%	$15,899,000	1,089,381	+780,729	+253%	$14.59	Q3 2025
30 Jun 2025	0.01%	+0%	$3,401,000	308,652	+134,058	+77%	$11.02	Q2 2025
31 Mar 2025	0%	+0%	$1,554,000	174,594	+174,451	+121900%	$8.90	Q1 2025
31 Dec 2024	0%	-0%	$1,000	143	-69,166	-100%	$6.99	Q4 2024
30 Sep 2024	0%	+0%	$557,000	69,309	+69,309	NEW	$8.04	Q3 2024
30 Jun 2022		-0%	$0	0	-8,277	-100%	$19.99	Q2 2022
31 Mar 2022	0%	+0%	$77,000	8,277	+2,818	+52%	$9.30	Q1 2022
31 Dec 2021	0%	-0%	$60,000	5,459	-43,843	-89%	$10.99	Q4 2021
30 Sep 2021	0%	+0%	$362,000	49,302	+49,302	NEW	$7.34	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.